The effects of different doses of transdermal estradiol (TE) on bone mineral density (BMD) in a man with aromatase deficiency were evaluated. The study protocol was divided in the following four phases: phase 1, before estradiol treatment; phase 2, 50 mu g TE twice weekly for 6 months; phase 3, 25 mu g TE twice weekly for 9 months; and phase 4, 12.5 mu g TE twice weekly for 9 months. X-rays of hands, legs, and pelvis were performed, and BMD of the lumbar spine, hormonal parameters (LH, FSH, testosterone, and estradiol), and markers of bone turnover were determined during each phase. BMD in phase 1 was 0.933 g/cm(2) and increased to 1.051 and 1.173 g/cm(2) after 4 and 7 months of TE, respectively. In phase 3, BMD reached the maximum value (1.275 g/cm(2)). In phase 4, BMD decreased to 1.180 g/cm(2) and was 1.029 g/cm(2) at the end of the study protocol. A bilateral necrosis of femoral heads was also detected by x-ray films. In phase 1 serum testosterone was in the normal range, whereas serum estradiol was undetectable. During the 24-month period of treatment with TE (phases 2-4), estradiol was directly related to the amount of TE, whereas LH was inversely related to estradiol serum levels. Estradiol and gonadotropins reached optimal values only in phase 3, when FSH also was near normal; serum testosterone concentrations were normal in phases 3 and 4. This study confirms the role of estrogens in achieving and maintaining bone mineral content in the human male, providing further clinical tools useful in the management of bone loss in aromatase deficiency in the male, We suggest that the adequate substitutive dose of TE for maintaining both bone mass and normal estradiol serum levels in adult men with aromatase deficiency may be 25 mu g twice weekly (0.47 mu g/kg weekly).
Attenzione! Scheda prodotto non ancora validata dall'Ateneo
Dati e metadati della pubblicazione sono in fase di verifica da parte dell'Ateneo. In caso di errori o violazione dei diritti d'autore, contattare: email@example.com
|Anno di pubblicazione:||2000|
|Titolo:||Estrogen replacement therapy in a man with congenital aromatase deficiency: Effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters|
|Autori:||V. Rochira; Marco Faustini-Fustini; A. Balestrieri; C. Carani|
|Autori interni:||ROCHIRA, Vincenzo |
|Digital Object Identifier (DOI):||10.1210/jc.85.5.1841|
|Rivista:||THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM|
|Appare nelle tipologie:||Articolo su rivista|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris